Skip to main content

Notice for valoctocogene roxaparvovec (BioMarin Pharmaceuticals Australia Pty Ltd)

Active ingredients
valoctocogene roxaparvovec
Date of review outcome
Lapse date
Type
Orphan drug
Dosage form(s)
Intravenous Infusion
Indication
Treatment of haemophilia A
Therapeutic area
Haematology

Help us improve the Therapeutic Goods Administration site